James P. Edwards,David E. Kindrachuk,Christopher M. Mapes,Daniel J. Pippel,Jennifer D. Venable
申请号:
US13676595
公开号:
US08598189B2
申请日:
2012.11.14
申请国别(地区):
US
年份:
2013
代理人:
摘要:
Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for H4 receptor activity modulation and for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.